Motus GI Holdings Inc. Stock News

Motus GI Holdings, Inc. (NASDAQ:MOTS) Research analysts at Colliers Securities increased their FY2021 earnings estimates for shares of Motus GI in a research note issued to investors on Monday, November 15th. Colliers Securities analyst K. Bauser now expects that the company will earn ($0.36) per share for the year, up from their previous forecast []

Iovance Biotherapeutics, Inc. (IOVA) with the stream of 0.05% also noticed, India Motus GI Holdings, Inc. (MOTS) encountered a rapid change of 0.50% in the last hour of Tuesdays trading The post Take This As A Wake-Up Call: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), Motus GI Holdings, Inc. (NASDAQ:MOTS) appeared first on Stocks Equity .

Motus GI (NASDAQ:MOTS)s stock had its buy rating restated by analysts at HC Wainwright in a note issued to investors on Monday, TipRanks reports. They presently have a $2.00 price target on the stock. HC Wainwrights price objective indicates a potential upside of 218.02% from the companys previous close. Separately, Piper Sandler reduced their target []

Motus GI (NASDAQ:MOTS)s stock had its buy rating reiterated by analysts at HC Wainwright in a note issued to investors on Monday, TipRanks reports. They presently have a $2.00 price objective on the stock. HC Wainwrights target price points to a potential upside of 197.71% from the companys current price. Separately, Piper Sandler cut their []

Motus GI Holdings' (MOTS) CEO Tim Moran on Q3 2021 Results - Earnings Call Transcript

Motus GI Hldgs (NASDAQ:MOTS) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FORT LAUDERDALE, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve

Motus GI Holdings' (MOTS) CEO Tim Moran on Q2 2021 Results - Earnings Call Transcript

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.09% and 20.48%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve

FORT LAUDERDALE, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that

FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve

Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes�

It can be difficult to find cheap stocks worth buying. But these seven companies look promising and are all under $3.